DN-027262

N/A

Report date: 2024/09/24 17:46:34

Base Information

Drug NameDN-027262
Drug Alias NameDN027262
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionToll like receptor 8 agonistsAnti-HER2
TargetsToll like receptor 8Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai De Novo Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai De Novo Pharmatech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A